Skip to content


Toviaz (fesoterodine) is a small molecule pharmaceutical. Fesoterodine was first approved as Toviaz on 2007-04-20. It is used to treat urge urinary incontinence in the USA. It has been approved in Europe to treat overactive urinary bladder. Toviaz's patents are valid until 2027-06-07 (FDA).
Trade Name Toviaz
Common Name Fesoterodine
Indication overactive urinary bladder, urge urinary incontinence
Drug Class
Get full access now